(CSTL) Castle Biosciences - Performance -3.6% in 12m
CSTL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-54.12%
#80 in Peer-Group
Rel. Strength
35.54%
#4780 in Stock-Universe
Total Return 12m
-3.63%
#63 in Peer-Group
Total Return 5y
-46.92%
#57 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 34.67 USD |
| 52 Week Low | 15.80 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 92.74 |
| Buy/Sell Signal +-5 | -0.18 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CSTL (-3.6%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CSTL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CSTL
| Total Return (including Dividends) | CSTL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 25.51% | 2.09% | 4.55% |
| 3 Months | 2.00% | 2.27% | 10.78% |
| 12 Months | -3.63% | -10.84% | 14.71% |
| 5 Years | -46.92% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | CSTL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 95.3% | 18.8% | 79.2% |
| 3 Months | -38.5% | 71.5% | 92.9% |
| 12 Months | -52.7% | -84.3% | 44.2% |
| 5 Years | -70.1% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th91.50 | 22.94% | 20.04% |
| 3 Month | %th49.00 | -0.26% | -7.93% |
| 12 Month | %th69.00 | 8.08% | -15.99% |
| 5 Years | %th72.50 | -28.03% | -75.02% |
FAQs
Does Castle Biosciences (CSTL) outperform the market?
Yes,
over the last 12 months CSTL made -3.63%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months CSTL made 2.00%, while XBI made 2.27%.
Performance Comparison CSTL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CSTL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.4% | 21% | -29.4% | -18% |
| US NASDAQ 100 | QQQ | 4.6% | 20% | -31.6% | -19% |
| German DAX 40 | DAX | 5.5% | 25.5% | -42.4% | -34% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.7% | 21.4% | -27.4% | -21% |
| Hongkong Hang Seng | HSI | 5.8% | 19.7% | -45.2% | -39% |
| India NIFTY 50 | INDA | 5.8% | 23.4% | -29.2% | -3% |
| Brasil Bovespa | EWZ | 4% | 17.7% | -53.9% | -17% |
CSTL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.9% | 18.8% | -36.1% | -32% |
| Consumer Discretionary | XLY | 7% | 23.9% | -20.7% | -23% |
| Consumer Staples | XLP | 8.9% | 27.1% | -27.6% | -13% |
| Energy | XLE | 9.8% | 22% | -24% | 0% |
| Financial | XLF | 5.3% | 22.4% | -32.5% | -33% |
| Health Care | XLV | 6.3% | 23.5% | -22.2% | 2% |
| Industrial | XLI | 5.8% | 21.8% | -36% | -28% |
| Materials | XLB | 7.3% | 23.9% | -28.8% | -7% |
| Real Estate | XLRE | 9.9% | 25.5% | -26.8% | -16% |
| Technology | XLK | 4.1% | 16.6% | -32.7% | -15% |
| Utilities | XLU | 7.8% | 25.5% | -32.8% | -28% |
| Aerospace & Defense | XAR | 3.4% | 15.6% | -50.8% | -56% |
| Biotech | XBI | 7.5% | 23.4% | -15.5% | 7% |
| Homebuilder | XHB | 7.1% | 19.4% | -18.2% | -4% |
| Retail | XRT | 8.5% | 24.1% | -20.7% | -10% |
CSTL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 12.7% | 20.4% | -20.2% | 7% |
| Natural Gas | UNG | 17.6% | 34.9% | -14.3% | 4% |
| Gold | GLD | 10.3% | 27.7% | -49.3% | -45% |
| Silver | SLV | 8.8% | 21.7% | -48% | -26% |
| Copper | CPER | 5.1% | 21.3% | -49.1% | -19% |
CSTL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.6% | 21.9% | -26.2% | -6% |
| iShares High Yield Corp. Bond | HYG | 7.5% | 23.7% | -28.4% | -15% |